Mauna Kea Technologies receives CE Mark for Cellvizio in minimally invasive surgery

Mauna Kea Technologies’ Cellvizio technology has received a CE mark for use in minimally invasive laparoscopic surgical indications.

Advertisement

Cellvizio is designed to provide real-time visualization of tissue at the microscopic level. Through the expanded indication in Europe, Cellvizio could now be used in a wide range of oncologic surgical procedures.

More articles on gastroenterology:
9 gastroenterologists selected for ASGE’s ACE Program
Commonwealth Laboratories launches IBS blood test
Virginia Mason joins lawsuit against Olympus America – 5 key notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.